Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick N Harter

Showing results (191-200 of 205) with videos related to

Pageof 21
Sort By:
Cancer Discovery|June 9, 2021
AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant LeukemiaIrene Tirado-Gonzalez, Arnaud Descot, Devona Soetopo, et al.
Acta Neuropathologica Communications|January 11, 2022
Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survivalAzadeh Ebrahimi, Andrey Korshunov, Guido Reifenberger, et al.
Neuro-Oncology|April 18, 2025
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genesPhilipp Sievers, Sonali Arora, Thomas Hielscher, et al.
Acta Neuropathologica|April 20, 2021
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1Abigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerabilityRichard Drexler, Robin Khatri, Thomas Sauvigny, et al.
Nature Medicine|May 17, 2024
A prognostic neural epigenetic signature in high-grade gliomaRichard Drexler, Robin Khatri, Thomas Sauvigny, et al.
Brain Pathology (Zurich, Switzerland)|July 16, 2026
Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reportingKatrin Mauch-Mücke, Christin Siewert, Lora Dimitrova, et al.
Neuro-Oncology|September 30, 2025
Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registriesKatja von Hoff, Denise Obrecht-Sturm, David R Ghasemi, et al.
Nature Communications|July 20, 2023
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatmentMarkus Haake, Beatrice Haack, Tina Schäfer, et al.
Nature Medicine|July 11, 2018
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarateLukas Bunse, Stefan Pusch, Theresa Bunse, et al.
Pageof 21

Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
Cancer Discovery|June 9, 2021
AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant LeukemiaIrene Tirado-Gonzalez, Arnaud Descot, Devona Soetopo, et al.
Acta Neuropathologica Communications|January 11, 2022
Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survivalAzadeh Ebrahimi, Andrey Korshunov, Guido Reifenberger, et al.
Neuro-Oncology|April 18, 2025
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genesPhilipp Sievers, Sonali Arora, Thomas Hielscher, et al.
Acta Neuropathologica|April 20, 2021
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1Abigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerabilityRichard Drexler, Robin Khatri, Thomas Sauvigny, et al.
Nature Medicine|May 17, 2024
A prognostic neural epigenetic signature in high-grade gliomaRichard Drexler, Robin Khatri, Thomas Sauvigny, et al.
Brain Pathology (Zurich, Switzerland)|July 16, 2026
Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reportingKatrin Mauch-Mücke, Christin Siewert, Lora Dimitrova, et al.
Neuro-Oncology|September 30, 2025
Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registriesKatja von Hoff, Denise Obrecht-Sturm, David R Ghasemi, et al.
Nature Communications|July 20, 2023
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatmentMarkus Haake, Beatrice Haack, Tina Schäfer, et al.
Nature Medicine|July 11, 2018
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarateLukas Bunse, Stefan Pusch, Theresa Bunse, et al.
Pageof 21